SCHEMBL4011337

SCHEMBL4011337

Cc1cccc(C)c1NC(=O)C(Cl)C(Cl)C(=O)Nc1ccccc1C(F)(F)F

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 2/20 0.50
MAPK1 P28482 1/20 0.50
ALDH1A1 P00352 5/20 0.49
ALOX12 P18054 3/20 0.49
MEN1 O00255 2/20 0.49
KMT2A Q03164 2/20 0.49
KDM4E B2RXH2 1/20 0.49
HSP90AA1 P07900 1/20 0.49
ATM Q13315 1/20 0.49
TSHR P16473 1/20 0.48
HTT P42858 1/20 0.47
TRPV1 Q8NER1 1/20 0.46
CXCL8 P10145 1/20 0.45
LMNA P02545 1/20 0.45
NPSR1 Q6W5P4 2/20 0.44
MAPT P10636 1/20 0.44
PLA2G1B P04054 1/20 0.44
CYP1A2 P05177 1/20 0.44
CYP2C9 P11712 1/20 0.44
CYP2C19 P33261 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6716817 0.81 POLB (0.42) POLBMAPK1ALDH1A1ALOX12MEN1
SCHEMBL4011328 0.79 POLB (0.56) POLBALDH1A1ALOX12MEN1KMT2A
SCHEMBL10947190 0.79 ALDH1A1 (0.61) POLBMAPK1ALDH1A1MEN1KMT2A
SCHEMBL10668212 0.78 POLB (0.57) POLBMAPK1ALDH1A1MEN1KMT2A
SCHEMBL6716815 0.77 ALDH1A1 (0.53) POLBMAPK1ALDH1A1ALOX12MEN1
SCHEMBL11620551 0.75 ALDH1A1 (0.73) POLBMAPK1ALDH1A1MEN1KMT2A
SCHEMBL6717319 0.75 ALDH1A1 (0.54) POLBMAPK1ALDH1A1ALOX12LMNA
SCHEMBL24385583 0.75 ALDH1A1 (0.59) POLBMAPK1ALDH1A1ALOX12MEN1
SCHEMBL6717325 0.74 POLB (0.43) POLBMAPK1ALDH1A1ALOX12MEN1
Chloromethane SCHEMBL10795405 0.72 POLB (0.56) POLBMAPK1ALDH1A1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7528134-B2 Acetamides and benzamides that are useful in treating sexual dysfunction ABBOTT LABORATORIES INC. (US) 2009-05-05 US disclosed
US-20060009461-A1 Acetamides and benzamides that are useful in treating sexual dysfunction BHATIA PRAMILA A 2006-01-12 US disclosed
US-20040029887-A1 Acetamides and benzamides that are useful in treating sexual dysfunction ABBOTT LABORATORIES 2004-02-12 US disclosed
US-20030232836-A1 Acetamides and benzamides that are useful in treating sexual dysfunction ABBOTT LABORATORIES 2003-12-18 US disclosed
US-20030229094-A1 Acetamides and benzamides that are useful in treating sexual dysfunction ABBOTT LABORATORIES 2003-12-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030229094-A1 Acetamides and benzamides that are useful in treating sexual dysfunction CATSPER1, CYP19A1, PDE12 POLB 3627/4885MAPK1 2344/4885ALDH1A1 88/4885
US-20040029887-A1 Acetamides and benzamides that are useful in treating sexual dysfunction CATSPER1, CYP19A1, PDE12 POLB 3627/4885MAPK1 2344/4885ALDH1A1 88/4885
US-20060009461-A1 Acetamides and benzamides that are useful in treating sexual dysfunction PDE12, NAAA, CYP19A1 POLB 3383/4885MAPK1 3775/4885ALDH1A1 193/4885
US-20030232836-A1 Acetamides and benzamides that are useful in treating sexual dysfunction CATSPER1, CYP19A1, PDE12 POLB 3627/4885MAPK1 2344/4885ALDH1A1 88/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.